Simulations Plus Wins Cooperative Agreement with FDA

Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has been notified by the U.S. Food and Drug Administration (FDA) that the company has been awarded a $200,000 cooperative agreement to develop improved modeling and simulation capabilities for dosage forms designed to be applied to the eye.

Please to read the entire article.